With that regulatory brake reduced, IGF-1 LR3 interacts with IGF-1 receptors more directly and for a longer duration, which is why research protocols report a half-life of roughly 2030 hours, compared to native IGF-1s 1215 hours
10.1089/ars.2010.3586 Antioxid Redox
Semaglutide, marketed as Ozempic for diabetes and Wegovy for obesity, has emerged as the commercial powerhouse, with the oral version launching in January 2026 following December 2025 FDA approval [3]
I feel really good, she said
However, theres no doubt that GLP-1 drugs are accelerating interest in protein to address the loss of lean muscle mass associated with rapid weight loss from these drugs
Metabolism of glucose in the RBC is entirely anaerobic, consistent with the primary role of the RBC in oxygen transport and delivery, rather than its utilization